VTVT vTv Therapeutics Inc.: Rasio rega marang prakiraan pendapatan

vTv Therapeutics - logo grafis emiten VTVT

The development of TTP399 with FDA support and streamlined international drug distribution logistics ensure high margins for vTv Therapeutics Inc. (VTVT). The GURU.Markets service provides this chart, where the company's modeled P/S reaches a value of 1.90, capturing market expectations. The current strategy is based on scaling clinical trials of the innovative molecule for a subsequent global market entry into diabetes therapy.

vTv Therapeutics, Inc. - Rasio kapitalisasi marang dodolan sing dikarepake VTVT (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis vTv Therapeutics Inc (VTVT)

Ringkesan analitik perusahaan:vTv Therapeutics Inc (VTVT)
Produk asli vTv Therapeutics, Inc.

Forward P/S determines the market value of a business relative to expected revenue, allowing for the identification of an undervalued asset or the risk of a "value trap." By analyzing the forward P/S of vTv Therapeutics Inc. (VTVT), an investor assesses the capitalization rate of projected sales, which is critical for vTv Therapeutics Inc. (VTVT) due to its dependence on clinical trial outcomes and the difficulty of raising capital amid low cash flow predictability.

Perusahaan pesaing

Rasio rega marang prakiraan pendapatan ascendispharma.com ASND|Madrigal Corp (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MoonLake Corp|Crinetics Corp (CRNX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan newamsterdampharma.com (NAMS)|Multiplikator forward rega marang pendapatan soleno.life SLNO|Multiplikator Forward P/S FOLD (amicusrx.com)|Rasio kapitalisasi marang dodolan sing dikarepake 89bio (ETNB)|Agios - Multiplikator Forward P/S|Structure Corp - Rasio rega marang pendapatan sing dikarepake|mimedx.com (MDXG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan MBX|Rasio rega marang prakiraan pendapatan Altimmune Pharma (ALT)|Rasio rega marang prakiraan pendapatan AARD (Aardvark Therapeutics Corp)|Multiplikator Forward P/S SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BMEA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Multiplikator forward rega marang pendapatan|ATPC: Rasio rega marang pendapatan sing dikarepake|PLUR (pluri-biotech.com) - Multiplikator Forward P/S|SYBX: Rega forward marang dodolan|Multiplikator Forward P/S LPCN|Rasio kapitalisasi marang dodolan sing dikarepake Matinas BioPharma Holdings, Inc.|Rasio rega marang prakiraan pendapatan Spruce Biosciences Inc. SPRB|GLTO - Multiplikator forward rega marang pendapatan|CTCX - Rasio rega marang prakiraan pendapatan|LUMO - Multiplikator Forward P/S|ONVO: Multiplikator Forward P/S|RDUS (Radius Recycling) - Rasio rega marang prakiraan pendapatan